Rocket Lab Corp. (NASDAQ: RKLB) saw its shares close at an all-time high on Tuesday, extending a post-earnings surge that has shifted investor focus squarely onto the company's upcoming Neutron rocket and its expanding defense portfolio. The stock has climbed more than 40% over two trading sessions following the release of its first-quarter financial results, according to MarketBeat.
The rally reflects a broader revaluation of Rocket Lab beyond its reputation as a small-launch specialist. The company now designs and manufactures rockets, spacecraft, satellite components, and software, with revenue streams from both launch services and space systems. This diversification has become increasingly central to its investment thesis.
Defense Catalyst and Financial Metrics
A significant catalyst emerged from the defense sector. The Congressional Budget Office estimated Tuesday that the U.S. Golden Dome missile-defense shield could cost approximately $1.2 trillion over two decades. Rocket Lab recently announced its selection alongside RTX's Raytheon to demonstrate capabilities for the Space Force's Space Based Interceptor program, an orbiting system designed to intercept missiles earlier in flight.
The company reported first-quarter revenue of $200.3 million, a 63.5% increase year-over-year, with a backlog of $2.2 billion. Management guided second-quarter revenue between $225 million and $240 million, which would represent another record if achieved.
Neutron Orders and Backlog Details
The most notable booking was a confidential customer order for five Neutron launches and three Electron launches scheduled between 2026 and 2029. Rocket Lab disclosed that this deal brought its total manifest to over 70 missions, though full financial terms were not revealed.
Defense contracts are also bolstering near-term visibility. The company secured a $30 million contract with Anduril for three HASTE hypersonic test launches from Virginia. HASTE is a suborbital test variant of the Electron rocket designed for payloads exceeding Mach 5. CEO Sir Peter Beck emphasized the vehicle's “speed, affordability, and reliable hypersonic technology testing,” while Anduril executive Gokul Subramanian described the work as “one of the most complex problems in defense.”
Analyst Divergence and Competitive Landscape
Wall Street analysts remain divided on the stock's trajectory. Deutsche Bank analyst Edison Yu raised his price target to $120 from $73, maintaining a buy rating, as reported by TheStreet Pro. In contrast, Goldman Sachs analyst Noah Poponak kept a neutral stance even after lifting his target to $76 from $73, according to TipRanks.
The competitive environment remains intense. Rocket Lab is positioning Neutron as a rival to SpaceX's Falcon 9. BryceTech founder Carissa Christensen told Aerospace America that Neutron is competing against “arguably the most successful launch vehicle ever” and must carve out clear niches to succeed.
Risks and Market Sentiment
Despite the stock's momentum, risks persist. The company reported a net loss of $45.0 million in the first quarter. Additionally, only about 36% of the remaining backlog is expected to be recognized within 12 months, and a single government customer accounted for 36% of quarterly revenue.
Prediction markets reflect caution around Neutron's timeline. On a thinly traded Polymarket contract, traders assigned a 52% probability of a Neutron launch by December 31, with the market resolving upon liftoff from the pad, not on mission success.
Rocket Lab is also expanding its supply chain. The company agreed to acquire Motiv Space Systems, a robotics and motion-control supplier, with the deal expected to close in the second quarter subject to customary conditions.
For now, the market is pricing in future proof points. Rocket Lab holds contracts, defense exposure, and a larger rocket nearing the center of its equity narrative. The next phase depends less on the rally itself and more on whether Neutron and the defense backlog translate into recurring revenue without costly delays.
